Dr. Li is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MGH Diabetes Center
50 Staniford St #340
Boston, MA 02114Phone+1 617-726-8722Fax+1 617-724-8534
Summary
- Dr. Li is an endocrinologist in the Diabetes Unit at Massachusetts General Hospital and faculty at Harvard Medical School. She received her medical degree from Duke University School of Medicine. She completed a residency in internal medicine at Beth Israel Deaconess Medical Center in Boston and her endocrinology fellowship at Massachusetts General Hospital.
Dr. Li specializes in treating endocrine disorders with a focus on diabetes. She conducts research on the genetic predictors of response to glucose-lowering medications for type 2 diabetes.
Education & Training
Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2017 - 2020
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2014 - 2017
Duke University School of MedicineClass of 2014, MD
Certifications & Licensure
MA State Medical License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH Start of enrollment: 2024 Mar 12
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Algorithms for the identification of prevalent diabetes in the All of Us Research Program validated using polygenic scores.Lukasz Szczerbinski, Ravi Mandla, Philip Schroeder, Bianca C Porneala, Josephine H Li
Scientific Reports. 2024-11-06 - Publisher Correction: Rare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes.Alicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, Jiang Li, Lowri Morris
Nature Genetics. 2024-11-01 - 2 citationsRare variant analyses in 51,256 type 2 diabetes cases and 370,487 controls reveal the pathogenicity spectrum of monogenic diabetes genes.Alicia Huerta-Chagoya, Philip Schroeder, Ravi Mandla, Jiang Li, Lowri Morris
Nature Genetics. 2024-11-01
Press Mentions
Genetic Variants May Affect Treatment Response to Commonly Prescribed Type 2 Diabetes MedicationJune 3rd, 2023- Genetic Variation Linked to Treatment Response to Commonly Prescribed Type 2 Diabetes MedicationJune 5th, 2023
Professional Memberships
- Member
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
